Sensus Healthcare, Inc. Contract Liability (Deferred Revenue)
Sensus Healthcare, Inc. (SRTS) had Contract Liability (Deferred Revenue) of $686.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-11-14
- 2024-09-30: Contract with Customer, Liability, Current $686.00K.
- 2024-06-30: Contract with Customer, Liability, Current $686.00K.
- 2023-12-31: Contract with Customer, Liability, Current $657.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-09-30 | $686.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $686.00K 10-Q · filed 2024-08-13 |
| 2023-12-31 | $657.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |